The cost effectiveness of imatinib mesylate was estimated by extrapolating long-term survival and costs from the pivotal multicentre trial of 147 patients with advanced GIST receiving imatinib ...

The objective of this study was to estimate the cost effectiveness of imatinib mesylate in the treatment of GIST. Methods: A cost-effectiveness model of GIST treatment was developed. Long- term ...

How do scientists develop new treatments for disease? With Gleevec, a remarkable cancer drug, the approach was to target the disease at the cellular and subcellular level. When people say Gleevec ...

In 2001, a Time Magazine cover story touted Novartis’ targeted leukemia treatment Gleevec (imatinib) as a new kind of “ammunition in the war against cancer.” Along with a picture of the ...